Related references
Note: Only part of the references are listed.Perivascular spaces in the brain: anatomy, physiology and pathology
Joanna M. Wardlaw et al.
NATURE REVIEWS NEUROLOGY (2020)
Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders
Bob Olsson et al.
JAMA NEUROLOGY (2019)
The contribution of astrocytes to the neuroinflammatory response in multiple sclerosis and experimental autoimmune encephalomyelitis
Roberta Brambilla
ACTA NEUROPATHOLOGICA (2019)
CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease
Shorena Janelidze et al.
NEUROLOGY (2018)
ASSESSMENT OF A NUTRITIONAL SUPPLEMENT CONTAINING RESVERATROL, PREBIOTIC FIBER, AND OMEGA-3 FATTY ACIDS FOR THE PREVENTION AND TREATMENT OF MILD TRAUMATIC BRAIN INJURY IN RATS
Sabrina Salberg et al.
NEUROSCIENCE (2017)
The Prevalence and Incidence of Dementia Due to Alzheimer's Disease: a Systematic Review and Meta-Analysis
Kirsten M. Fiest et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2016)
The amyloid hypothesis of Alzheimer's disease at 25years
Dennis J. Selkoe et al.
EMBO MOLECULAR MEDICINE (2016)
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
Bob Olsson et al.
LANCET NEUROLOGY (2016)
Effect of Docosahexaenoic Acid on a Biomarker of Head Trauma in American Football
Jonathan M. Oliver et al.
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE (2016)
Omega-3 Polyunsaturated Fatty Acids and Oxylipins in Neuroinflammation and Management of Alzheimer Disease
Jessay Gopuran Devassy et al.
ADVANCES IN NUTRITION (2016)
Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression
Henrik Zetterberg et al.
JAMA NEUROLOGY (2016)
Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer's disease in a memory clinic cohort
Maartje I. Kester et al.
ALZHEIMERS RESEARCH & THERAPY (2015)
Neuropsychiatric symptoms in dementia-A role for neuroinflammation?
Simon Holmgren et al.
BRAIN RESEARCH BULLETIN (2014)
Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study
Y. Freund Levi et al.
JOURNAL OF INTERNAL MEDICINE (2014)
Body Fluid Cytokine Levels in Mild Cognitive Impairment and Alzheimer's Disease: a Comparative Overview
Frederic Brosseron et al.
MOLECULAR NEUROBIOLOGY (2014)
Omega-3 Fatty Acids Enhance Phagocytosis of Alzheimer's Disease-Related Amyloid-beta(42) by Human Microglia and Decrease Inflammatory Markers
Erik Hjorth et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Cerebrospinal Fluid (CSF) 25-Hydroxyvitamin D Concentration and CSF Acetylcholinesterase Activity Are Reduced in Patients with Alzheimer's Disease
Per Johansson et al.
PLOS ONE (2013)
Altered ?-secretase activity in mild cognitive impairment and Alzheimer's disease
Nobuto Kakuda et al.
EMBO MOLECULAR MEDICINE (2012)
Changes in CSF acetyl- and butyrylcholinesterase activity after long-term treatment with AChE inhibitors in Alzheimer's disease
L. Parnetti et al.
ACTA NEUROLOGICA SCANDINAVICA (2011)
Cerebrospinal Fluid Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Combination with Subcortical and Cortical Biomarkers in Vascular Dementia and Alzheimer's Disease
Maria Bjerke et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
YKL-40: A Novel Prognostic Fluid Biomarker for Preclinical Alzheimer's Disease
Rebecca Craig-Schapiro et al.
BIOLOGICAL PSYCHIATRY (2010)
Effects of Omega-3 Fatty Acids on Inflammatory Markers in Cerebrospinal Fluid and Plasma in Alzheimer's Disease: The OmegAD Study
Yvonne Freund-Levi et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2009)
CSF biomarker levels in early and late onset Alzheimer's disease
Femke H. Bouwman et al.
NEUROBIOLOGY OF AGING (2009)
Eicosapentaenoic acid inhibits interleukin-6 production in interleukin-1β-stimulated C6 glioma cells through peroxisome proliferator-activated receptor-gamma
Akiko Kawashima et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2008)
Eicosapentaenoic acid confers neuroprotection in the amyloid-β challenged aged hippocampus
Aileen M. Lynch et al.
NEUROBIOLOGY OF AGING (2007)
Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-β and tau pathology via a mechanism involving presenilin 1 levels
Kim N. Green et al.
JOURNAL OF NEUROSCIENCE (2007)
ω-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease:: OmegAD study -: A randomized double-blind trial
Yvonne Freund-Levi et al.
ARCHIVES OF NEUROLOGY (2006)
In vivo butyrylcholinesterase activity is not increased in Alzheimer's disease synapses
DE Kuhl et al.
ANNALS OF NEUROLOGY (2006)
A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease
WJ Lukiw et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model
GP Lim et al.
JOURNAL OF NEUROSCIENCE (2005)
CSF markers for incipient Alzheimer's disease
K Blennow et al.
LANCET NEUROLOGY (2003)
Cerebrospinal fluid beta-amyloid 42 is reduced before the onset of sporadic dementia: A population-based study in 85-year-olds
I Skoog et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2003)
Highly conserved and disease-specific patterns of carboxyterminally truncated Aβ peptides 1-37/38/39 in addition to 1-40/42 in Alzheimer's disease and in patients with chronic neuroinflammation
J Wiltfang et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Elevation of β-amyloid peptide 2-42 in sporadic and familial Alzheimer's disease and its generation in PS1 knockout cells
J Wiltfang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke
C Hesse et al.
NEUROSCIENCE LETTERS (2001)
Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment
JA Conquer et al.
LIPIDS (2000)
Share Paper
